Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)AGN-242428 in the Treatment of Plaque Psoriasis
- First Posted Date
- 2017-11-13
- Last Posted Date
- 2021-04-06
- Lead Sponsor
- Vitae Pharmaceuticals, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT03339999
- Locations
- 🇺🇸
Total Skin and Beauty Dermatology Center, PC, Birmingham, Alabama, United States
🇺🇸Radiant Tucson, Tucson, Arizona, United States
🇺🇸Johnson Dermatology, Fort Smith, Arkansas, United States
An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic Dermatitis
Phase 1
Completed
- Conditions
- Dermatitis, Atopic
- Interventions
- First Posted Date
- 2016-01-14
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- Vitae Pharmaceuticals, Inc.
- Target Recruit Count
- 104
- Registration Number
- NCT02655679
- Locations
- 🇺🇸
Dundee Dermatology, West Dundee, Illinois, United States
🇺🇸Hamzavi Dermatology, Fort Gratiot, Michigan, United States
🇺🇸Skin Specialty Dermatology, New York, New York, United States
Direct Renin Inhibition and the Kidney
- First Posted Date
- 2010-10-08
- Last Posted Date
- 2016-02-29
- Lead Sponsor
- Vitae Pharmaceuticals, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT01217736
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
News
No news found